Asset Planning Services (Pennsylvania)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Asset Planning Services (Pennsylvania)'s BMY.RT Position: Q1 2021 in Review
Asset Planning Services (Pennsylvania) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,421 shares — an estimated $11K sold.
Asset Planning Services (Pennsylvania) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $59K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Asset Planning Services (Pennsylvania) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Asset Planning Services (Pennsylvania) sold 15,421 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
- Asset Planning Services (Pennsylvania) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
- Asset Planning Services (Pennsylvania)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $59K in Q1 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q1 2021, filed 11 May 2021.